sábado, 8 de noviembre de 2014

Ahead of Print -Human Hantavirus Infections in the Netherlands - Volume 20, Number 12—December 2014 - Emerging Infectious Disease journal - CDC

full-text ►

Ahead of Print -Human Hantavirus Infections in the Netherlands - Volume 20, Number 12—December 2014 - Emerging Infectious Disease journal - CDC



CDC. Centers for Disease Control and Prevention. CDC 24/7: Saving Lives. Protecting People.

Volume 20, Number 12—December 2014

Dispatch

Human Hantavirus Infections in the Netherlands

Jussi SaneComments to Author , Johan Reimerink, Margriet Harms, Jacinta Bakker, Lapo Mughini-Gras, Barbara Schimmer, and Wilfrid van Pelt
Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (J. Sane, J. Reimerink, M. Harms, J. Bakker, L. Mughini-Gras, B. Schimmer, W. van Pelt)European Centre for Disease Prevention and Control, Stockholm, Sweden (J. Sane)

Abstract

We report the recent epidemiology and estimated seroprevalence of human hantavirus infections in the Netherlands. Sixty-two cases were reported during December 2008–December 2013. The estimated seroprevalence in the screened municipalities in 2006–2007 was 1.7% (95% CI 1.3%–2.3%). Findings suggest that hantavirus infections are underdiagnosed in the Netherlands.
Hantaviruses (family Bunuyaviriade, genus Hantavirus) are primarily rodent-borne pathogens that are a suspected cause of hemorrhagic fever with renal syndrome (HFRS) in Eurasia (1). They are transmitted to humans mainly through aerosolized rodent excreta (1). Five hantaviruses circulate among rodents in Europe, but most human HFRS cases are caused by Puumala virus (PUUV) (1,2). The reservoir for PUUV is bank voles (Myodes glareolus), which are widespread in Europe (1,2). HFRS is a reportable disease in most countries in Europe, and cases are reported mostly from Finland, Sweden, and forest-rich regions of Belgium and Germany (1,3,4).
In the Netherlands, hantavirus infections have been reportable since December 2008, although voluntary laboratory surveillance has been in place since 1989. An earlier study in the Netherlands reported a seroprevalence of 0.7% among blood donors but higher prevalences in forest workers and animal trappers (5). Antibodies to PUUV, Tula virus (TULV), and Seoul virus (SEOV) have been found in rodent populations in the Netherlands, and TULV has been isolated from common voles (Microtus arvalis) (5,6). The purpose of this study was to report recent trends in human hantavirus infection and estimate seroprevalence in the Netherlands.

Dr Sane is a fellow in the European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, at National Institute for Public Health and the Environment, Bilthoven, the Netherlands. His primary research interests include epidemiology of viral diseases, especially vaccine-preventable and vector-borne infections.

Acknowledgments

We thank Chantal Reusken for contributing to the study design and manuscript preparation.
J.S. was supported by the European Programme for Intervention Epidemiology Training, European Centre for Disease Prevention and Control.

References

  1. Vaheri AHenttonen HVoutilainen LMustonen JSironen TVapalahti OHantavirus infections in Europe and their impact on public health. Rev Med Virol2013;23:3549DOIPubMed
  2. Olsson GELeirs HHenttonen HHantaviruses and their hosts in Europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Dis2010;10:54961DOIPubMed
  3. Ahlm CLinderholm MJuto PStegmayr BSettergren BPrevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol Infect1994;113:12936DOIPubMed
  4. Zöller LFaulde MMeisel HRuh BKimmig PSchelling USeroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis1995;14:30513DOIPubMed
  5. Groen JGerding MNJordans JGClement JPNieuwenhuijs JHOsterhaus ADHantavirus infections in The Netherlands: epidemiology and disease. Epidemiol Infect1995;114:37383DOIPubMed
  6. Reusken Cde Vries AAdema JVos Wvan der Giessen JBekker DFirst genetic detection of Tula hantavirus in wild rodents in the Netherlands. J Infect2008;57:5003DOIPubMed
  7. van der Klis FRMollema LBerbers GAde Melker HECoutinho RASecond national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med2009;67:3018 .PubMed
  8. Jameson LJLogue CHAtkinson BBaker NGalbraith SECarroll MWThe continued emergence of hantaviruses: isolation of a Seoul virus implicated in human disease, United Kingdom, October 2012. Euro Surveill2013;18:47 .PubMed
  9. Macé GFeyeux CMollard NChantegret CAudia SRebibou JMSevere Seoul hantavirus infection in a pregnant woman, France, October 2012.Euro Surveill2013;18:20464 .PubMed
  10. Makary PKanerva MOllgren JVirtanen MJVapalahti OLyytikainen ODisease burden of Puumala virus infections, 1995–2008. Epidemiol Infect.2010;138:148492DOIPubMed
  11. Faber MSUlrich RGFrank CBrockmann SOPfaff GMJacob JSteep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill.2010;15:19574 .PubMed
  12. Schwarz ACRanft UPiechotowski IChilds JEBrockmann SORisk factors for human infection with Puumala virus, southwestern Germany. Emerg Infect Dis2009;15:10329DOIPubMed
  13. Voutilainen LSavola SKallio ERLaakkonen JVaheri AVapalahti OEnvironmental change and disease dynamics: effects of intensive forest management on Puumala hantavirus infection in boreal bank vole populations. PLoS ONE2012;7:e39452DOIPubMed
  14. Hjertqvist MKlein SLAhlm CKlingstrom JMortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis2010;16:15846DOIPubMed
  15. Krautkrämer EGrouls SUrban ESchnitzler PZeier MNo gender-related differences in the severity of nephropathia epidemica, Germany. BMC Infect Dis2013;13:457 . DOIPubMed

Figures

Table

Suggested citation for this article: Sane J, Reimerink J, Harms M, Bakker J, Mughini-Gras L, Schimmer B, et al. Human hantavirus infections in the Netherlands. Emerg Infect Dis [Internet]. 2014 Dec [date cited]. http://dx.doi.org/10.3201/eid2012.131886
DOI: 10.3201/eid2012.131886

No hay comentarios:

Publicar un comentario